000			01942 a2200565 4500
005			20250518031414.0
264		0	_c20191206
008			201912s 0 0 eng d
022			_a1651-226X
024	7		_a10.1080/0284186X.2019.1581374 _2doi
040			_aNLM _beng _cNLM
100	1		_aSkau Rasmussen, Louise
245	0	0	_aThe effect of postoperative gemcitabine on overall survival in patients with resected pancreatic cancer: A nationwide population-based Danish register study. _h[electronic resource]
260			_bActa oncologica (Stockholm, Sweden) _cJun 2019
300			_a864-871 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdenocarcinoma _xpathology
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntimetabolites, Antineoplastic _xtherapeutic use
650	0	4	_aDenmark _xepidemiology
650	0	4	_aDeoxycytidine _xanalogs & derivatives
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPancreatectomy _xadverse effects
650	0	4	_aPancreatic Neoplasms _xpathology
650	0	4	_aPostoperative Complications _xdrug therapy
650	0	4	_aPrognosis
650	0	4	_aProspective Studies
650	0	4	_aSurvival Rate
650	0	4	_aGemcitabine
700	1		_aVittrup, Benny
700	1		_aLadekarl, Morten
700	1		_aPfeiffer, Per
700	1		_aKaren Yilmaz, Mette
700	1		_aØstergaard Poulsen, Laurids
700	1		_aØsterlind, Kell
700	1		_aPalnæs Hansen, Carsten
700	1		_aBau Mortensen, Michael
700	1		_aViborg Mortensen, Frank
700	1		_aSall, Mogens
700	1		_aDetlefsen, Sönke
700	1		_aBøgsted, Martin
700	1		_aWilki Fristrup, Claus
773	0		_tActa oncologica (Stockholm, Sweden) _gvol. 58 _gno. 6 _gp. 864-871
856	4	0	_uhttps://doi.org/10.1080/0284186X.2019.1581374 _zAvailable from publisher's website
999			_c29510575 _d29510575